Difference between revisions of "Template:Antithrombotics"
Jump to navigation
Jump to search
(Betrixaban was FDA approved on 6/23/17.) |
blackwiki>Anypodetos m (Fix link) |
||
| Line 146: | Line 146: | ||
| list3 = | | list3 = | ||
* [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]] | * [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]] | ||
| − | ** [[ | + | ** [[Alteplase]] |
** [[Reteplase]] | ** [[Reteplase]] | ||
** [[Tenecteplase]] | ** [[Tenecteplase]] | ||
Revision as of 11:31, 16 December 2017
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Antithrombotics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Antithrombotics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Antithrombotics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.